HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 45 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -81.8% | 12,049 | -62.3% | 0.00% | -50.0% |
| Q4 2019 | $22,000 | -4.3% | 31,991 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | -55.8% | 35,037 | +12.6% | 0.00% | -33.3% |
| Q2 2019 | $52,000 | -36.6% | 31,122 | -3.3% | 0.00% | -25.0% |
| Q4 2018 | $82,000 | -61.9% | 32,191 | -24.5% | 0.00% | -69.2% |
| Q3 2018 | $215,000 | -24.3% | 42,664 | -45.6% | 0.01% | -13.3% |
| Q1 2018 | $284,000 | +165.4% | 78,360 | +24.0% | 0.02% | +200.0% |
| Q3 2017 | $107,000 | – | 63,172 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |